Alfavision Overseas (India) Limited (BOM:531156)
India
· Delayed Price · Currency is INR 5.52
+0.92 (20.00%)
At close: Mar 9, 2026
BOM:531156 Revenue
Alfavision Overseas (India) had revenue of 13.30M INR in the twelve months ending December 31, 2025, down -33.89% year-over-year. In the fiscal year ending March 31, 2025, Alfavision Overseas (India) had annual revenue of 19.06M, down -39.05%.
Revenue (ttm)
13.30M
Revenue Growth
-33.89%
P/S Ratio
13.09
Revenue / Employee
1.48M
Employees
9
Market Cap
174.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.06M | -12.21M | -39.05% |
| Mar 31, 2024 | 31.27M | -276.84M | -89.85% |
| Mar 31, 2023 | 308.11M | -1.51B | -83.03% |
| Mar 31, 2022 | 1.82B | 24.74M | 1.38% |
| Mar 31, 2021 | 1.79B | 221.17M | 14.09% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Link Pharma Chem | 272.89M |
| Supha Pharmachem | 5.27B |
| Venmax Drugs and Pharmaceuticals | 44.14M |
| Ishita Drugs and Industries | 161.68M |
| Crestchem | 266.14M |
| Vasundhara Rasayans | 315.86M |
| Bacil Pharma | 5.48M |
| Tyche Industries | 505.54M |